When China’s Academy of Medical Science announced that it was screening some 30 drugs as potential treatments for the deadly coronavirus outbreak, few thought that many were actually being repurposed.
China Uses Old To Fight New As Repurposed Drugs Take Coronavirus Role
Antimalarial Among Those Added To Guidelines
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.

More from Anti-infective
More from Therapy Areas
• By
Investing heavily in antibody-drug conjugates, AbbVie is pioneering a dual STEAP1xPSMA-targeting approach in prostate cancer, as other candidates advance.
• By
Strong sales growth for the German group’s SGLT2 inhibitor in 2024
• By
The study’s failure in the overall MDD population was not a surprise, but solriamfetol’s efficacy in MDD with EDS provided a rationale for testing it in that subpopulation.